U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 1871 - 1880 of 15696

Washington

Nursing facility rate update

Approval Date: September 22, 2023
Effective Date: July 1, 2023

Massachusetts

This plan amendment updates the methods and standards used to determine rates of payment to community health centers.

Approval Date: September 22, 2023
Effective Date: April 1, 2023

Rhode Island

This amendment is to confirm in its state plan the eligibility requirements for the Medicare Savings Program eligibility groups.

Approval Date: September 22, 2023
Effective Date: April 1, 2023

Indiana

This amendment renews Indiana’s 1915(i) State Plan HCBS benefit.

Approval Date: September 21, 2023
Effective Date: October 1, 2023
Topics: Home and community based services

Virginia

Removes the federal requirement that practitioners obtain a DATA-Waiver or X-Waiver to prescribe medications, like buprenorphine, to treat patients with opioid use disorder, in accordance with Section 1262 of the Consolidated Appropriations Act, 2023. Providers who have a current license to practice and a Drug Enforcement Administration (DEA) registration authorizing the prescribing of Schedule III drugs may prescribe buprenorphine for the treatment of opioid use disorder or pain management.

Approval Date: September 21, 2023
Effective Date: April 1, 2023

New Mexico

This amendment is that the state will cover all preventive services assigned a grade of A or B by the U.S. Preventive Services Task Force (USPSTF), and all approved vaccines recommended by the Advisory Committee on Immunization Practices (ACIP), and their administration.

Approval Date: September 21, 2023
Effective Date: February 1, 2023

Kansas

This SPA proposes to update the language on the state’s Prescribed Drugs Limitations list on the Pharmacy state plan coverage pages.

Approval Date: September 21, 2023
Effective Date: July 1, 2023
Topics: Coverage Prescribed Drugs

Nebraska

This SPA proposes to update the language on the state’s excluded drug list on the Pharmacy state plan coverage pages.

Approval Date: September 21, 2023
Effective Date: July 1, 2023

Georgia

This amendment is to adopt the changes to the eligibility rules for the Former Foster Care Children eligibility group, as enacted by the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, Pub. L. No. 115-217, section 1002.

Approval Date: September 21, 2023
Effective Date: January 1, 2023
Topics: Eligibility Medicaid and CHIP Program (MACPro)

Massachusetts

This plan amendment updates the professional dispensing fee when medications are delivered to an individual’s residence.

Approval Date: September 21, 2023
Effective Date: May 12, 2023